Not Yet Recruiting
xDRIVE in Metastatic Colorectal Cancer
NCT06929338
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +15 more
- Locations
-
Not specified
Clinical trial condition
Metastatic Rectal Adenocarcinoma
Explore clinical trials studying Metastatic Rectal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
10 public trials
0 recruiting studies
Metastatic Rectal Adenocarcinoma trial results
NCT04109924
- Conditions
- Advanced Colorectal Carcinoma, Colonic Diseases, Colonic Neoplasms, +37 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT04362839
- Conditions
- Advanced Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer
NCT05130060
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +21 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial
NCT04599140
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +31 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation
NCT05308446
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +18 more
- Locations
-
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Mercy Cancer Center - Carmichael Carmichael, California, United States
- Mercy San Juan Medical Center Carmichael, California, United States
- Kaiser Permanente Dublin Dublin, California, United States
Active, Not Recruiting
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
NCT04616183
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +41 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
NCT04017650
- Conditions
- BRAF NP_004324.2:p.V600E, Colonic Diseases, Colonic Neoplasms, +30 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer
NCT02874885
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
NCT05627635
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States